Search Within

Lee M Krug

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (5)
Groups
  1. Department of Medicine (15)
  2. Department of Pathology and Laboratory Medicine (15)
  3. GSK Faculty (15)
  4. Human Oncology and Pathogenesis Program (15)
  5. Solid Tumor Oncology Division (15)
  6. Thoracic Oncology (15)

More Groups

People
  1. Marc Ladanyi (14)
  2. Marjorie Zauderer (7)
  3. Mark Kris (7)
  4. Michael Berger (7)
  5. Valerie Rusch (7)
  6. Anna Varghese (6)

More People

Years
  1. 2016 (1)
  2. 2015 (5)
  3. 2014 (3)
  4. 2013 (3)
  5. 2012 (2)
  6. 2011 (1)
Publications
  1. Journal of Thoracic Oncology (6)
  2. Journal of Clinical Oncology (5)
  3. Clinical Cancer Research (2)
  4. Annals of Oncology (1)
  5. Lung Cancer (1)
Publishers
  1. Elsevier Inc. (6)
  2. American Society of Clinical Oncology (5)
  3. American Association for Cancer Research (2)
  4. Elsevier Ireland Ltd. (1)
  5. Oxford University Press (1)

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective molecular evaluation of small cell lung cancer (SCLC) utilizing the comprehensive mutation analysis Program at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Pietanza, M. C.; Varghese, A.; Won, H.; Rekhtman, N.; Wang, L.; Travis, W. D.; Paik, P. K.; Riely, G. J.; Zakowski, M. F.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations
    Journal Article

    Zauderer, M. G.; Bott, M.; McMillan, R.; Sima, C. S.; Rusch, V.; Krug, L. M.; Ladanyi, M.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Clinical characteristics of patients with malignant pleural mesothelioma (MPM) harboring somatic BAP1 mutations
    Meeting Abstract

    Zauderer, M. G.; Bott, M. J.; McMillan, R.; Sima, C. S.; Rusch, V. W.; Krug, L. M.; Ladanyi, M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment
    Journal Article

    Ladanyi, M.; Zauderer, M. G.; Krug, L. M.; Ito, T.; McMillan, R.; Bott, M.; Giancotti, F.
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Molecular characteristics predict clinical outcomes: Prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene
    Journal Article

    Rizvi, N. A.; Rusch, V.; Pao, W.; Chaft, J. E.; Ladanyi, M.; Miller, V. A.; Krug, L. M.; Azzoli, C. G.; Bains, M.; Downey, R.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save